HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.

Abstract
Lymphatic filariasis is a major public health problem of tropical countries. Although its elimination is planned as global effort using mass drug administration in affected communities but its impact has been influenced by MDA coverage across countries. The drug coverage is affected by fever as side effect and its continuation for over 6 years which affect the population participation. Therefore alternative approaches are needed which can show impact faster than standard MDA. Present research using additional 12 days dose of DEC to mf carriers, show that if drug coverage could be regular, sustainable impact could be created in 4 years.
AuthorsAnil Kumar, Pawan Sachan, Ashis Bajpei, Tejveer Singh
JournalThe Journal of communicable diseases (J Commun Dis) 2013 Mar-Jun Vol. 45 Issue 1-2 Pg. 33-40 ISSN: 0019-5138 [Print] India
PMID25141552 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Filaricides
  • Diethylcarbamazine
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Diethylcarbamazine (administration & dosage, therapeutic use)
  • Drug Administration Schedule
  • Elephantiasis, Filarial (drug therapy, prevention & control)
  • Female
  • Filaricides (administration & dosage, therapeutic use)
  • Humans
  • India (epidemiology)
  • Male
  • Preventive Health Services (methods)
  • Rural Health
  • Rural Population
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: